Flag­ship re­cruits ex-Ma­gen­ta CEO to lead Am­per­sand; Bio­gen's head of re­search leaves for All­tr­na

Last Mon­day, Ja­son Gard­ner be­came the lat­est biotech vet­er­an to join the sprawl­ing biotech in­cu­ba­tor Flag­ship Pi­o­neer­ing as a CEO-part­ner and as chief ex­ec­u­tive of Am­per­sand Bio­med­i­cines, one of the firm’s star­tups that emerged from stealth ear­li­er this spring.

Gard­ner hopped over to Flag­ship af­ter about half a dozen years lead­ing Ma­gen­ta Ther­a­peu­tics, a biotech he found­ed. The jour­ney end­ed some­what abrupt­ly in the win­ter af­ter a pa­tient death in one of its clin­i­cal tri­als led to a quick in­ter­nal re­think and a sub­se­quent search for strate­gic al­ter­na­tives, which cul­mi­nat­ed in the biotech hand­ing its Nas­daq spot to a pri­vate start­up.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER